I'm curious as to whether their psychedelic trial plans will involve CBD in conjunction with a psychedelic agent.
The anxiolytic action of CBD could go some way toward countering the risks of 'bad trip' reactions to psilocybin, LSD, Mescaline, etc.
This would seem to be in keeping with the company's MO of exploring relatively low risk combinations of CBD + x.
Ann: Trading Halt, page-44
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)